Sanofi's venture arm backs 'digital' drug startup Click Therapeutics

Click plans to seek FDA approval for its "digital therapeutics" as a type of medical device, allowing them to be prescribed by physicians and reimbursed by insurers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.